by ARTILLERY | Oct 8, 2024 | News
Giving appropriate patients the option to self-administer¹ACTEMRA® (tocilizumab) is available in different routes of administration to meet patients’ needs. Some patients may prefer the ACTEMRA ACTPen® autoinjector, which is self-administered once a week or once every...
by ARTILLERY | Sep 9, 2024 | News
Payer coverage information for select RA patients in California 79% of patients in California have coverage for ACTEMRA® (tocilizumab) IV with no step edits.1 In a changing treatment landscape, Genentech remains committed to ensuring patients with rheumatoid arthritis...
by ARTILLERY | May 1, 2024 | News
In the battle against chronic diseases, patients face an unexpected adversary: ‘copay accumulators’ jeopardizing access to life-saving medications, forcing impossible choices between health and sustenance. CRA President, Samy Metyas, MD shares his opinion...
by ARTILLERY | Feb 16, 2024 | News
Pfizer’s Myositis Research Do you have patients with Dermatomyositis or Polymyositis who may be eligible to participate in an ongoing Phase 3 clinical research study? • This study is currently recruiting in 9 states in the USA and will add additional sites...
by ARTILLERY | Jan 10, 2024 | State Legislative Issues
California was the first state in the nation to pass legislation creating a health insurance exchange, known as Covered California, after the enactment of the federal Patient Protection and Affordable Care Act (ACA). The state continues to consider legislation...
